AVH vs CYC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AVH

AVITA MED CDI 5:1 [AVH]

50MEDIUM

CYC

CYCLOPHARM FPO [CYC]

41LOW

Score Breakdown

AVH CYC
Technical
44
41
Catalyst
53
51
Sentiment
50
50
Fundamental
58
69
Momentum
45
39
Risk Gate
46
50

Key Metrics

AVH Metric CYC
$173.9MMarket Cap$61.6M
426KAvg Volume (20d)345K
+0.3%Short InterestN/A
$1.98052-Week High$1.290
$1.00052-Week Low$0.450
-1.3%Daily Change-6.7%
$1.135Reference Price$0.490
N/AROE-49.3%
-62.7%Profit Margin-53.3%

Active Signals

AVH Signals

●RSI drifting toward oversold territory — worth watching
●MACD crossed bearish — momentum is fading
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Took a hit — down 18.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●Low P/S ratio (2.4x)

CYC Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.7x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (1.9x)
●Moderate revenue growth (+10%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare AVH and CYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AVH vs GSS →AVH vs HMD →AVH vs IBX →AVH vs NAN →AVH vs ONE →
AVH Full Analysis → CYC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).